Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency Investigation
Phase 4
Completed
- Conditions
- Myocardial Blood Flow Reserve
- Interventions
- Radiation: Rubidium-82
- First Posted Date
- 2013-08-09
- Last Posted Date
- 2018-08-16
- Lead Sponsor
- Timothy M. Bateman, MD
- Target Recruit Count
- 80
- Registration Number
- NCT01919450
- Locations
- 🇺🇸
Saint Luke's Hospital Imaging Center, Kansas City, Missouri, United States
News
No news found